Chronic fentanyl application induces adrenocortical insufficiency

K. M. Oltmanns*, H. L. Fehm, A. Peters

*Corresponding author for this work

Abstract

We report a case of a 64-year-old man with secondary adrenocortical insufficiency who has been on a chronic transdermal fentanyl treatment because of sciatic pain syndrome. Shortly before admission to our hospital, the patient had discontinued his hydrocortisone medication. Adrenal crisis was assumed and during therapy with hydrocortisone infusion, the patient recovered. We suspected an opiate-induced suppression of the hypothalamus-pituitary-adrenal (HPA) axis. Therefore, we gradually reduced the opiate dosage. After 1 week, HPA axis function was markedly improved. We conclude that opiate medication may inhibit - in a life-threatening way - the organism's ability to respond to physical, emotional or metabolic stressors.

Original languageEnglish
JournalJournal of Internal Medicine
Volume257
Issue number5
Pages (from-to)478-480
Number of pages3
ISSN0954-6820
DOIs
Publication statusPublished - 05.2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Chronic fentanyl application induces adrenocortical insufficiency'. Together they form a unique fingerprint.

Cite this